NASDAQ · Biotechnology

PRAX (PRAX) Stock

$303.02 -1.56% NASDAQ: PRAX Healthcare

Valuation

MetricValue
Price$303.02
Market Cap$8.45B
P/E Ratio-23.78
P/B Ratio7.72
P/S Ratio0.00
EPS (TTM)$-13.48
52-Week High$366.52
52-Week Low$37.19
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-34.51%
ROA-32.30%
ROCE-37.13%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio10.18

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$2.0M$9.0M$0
Operating Profit$-167.0M$-215.0M$-126.0M$-200.0M$-326.0M
Net Profit$-167.0M$-214.0M$-123.0M$-183.0M$-303.0M
EPS$-58.96$-69.33$-18.69$-10.21$-13.48
Op Margin——-5164.4%-2340.3%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$293.0M$115.0M$88.0M$483.0M$938.0M
Total Liabilities$42.0M$39.0M$18.0M$38.0M$60.0M
Cash$139.0M$62.0M$81.0M$215.0M$357.0M
Borrowings$4.0M$4.0M$2.0M$1.0M$0

Latest News

Praxis Precision Medicines (PRAX) Enters Into Licensing and Research Collaboration With Remagine Labs Insider Monkey · Jul 15, 2026 Goldman Sachs Initiates Praxis Precision Medicines at Buy With $447 Price Target MT Newswires · Jul 13, 2026 Praxis Precision Medicines Seen Having Greater Commercial Upside for Relutrigine, RBC Says MT Newswires · Jul 10, 2026 Praxis Precision Medicines and Remagine Labs Announce Strategic Collaboration to Develop Transdermal Ulixacaltamide for Essential Tremor GlobeNewswire · Jul 7, 2026 Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jul 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-125.0M$-185.0M$-111.0M$-132.0M$-249.0M
Investing Cash Flow$-142.0M$96.0M$39.0M$-248.0M$-311.0M
Financing Cash Flow$3.0M$1.0M$0$2.0M$-2.0M
Net Cash Flow$-157.0M$-78.0M$20.0M$134.0M$142.0M
Free Cash Flow$-126.0M$-185.0M$-111.0M$-132.0M$-249.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-4.17%
Quick Ratio15.88
Interest Coverage—
Return 1Y476.27%
Return 3Y1862.16%
Return 5Y22.49%

Ownership

Insiders Held0.28%
Institutions Held116.76%
Institutions Float Held117.08%
Institutional HolderSharesReport Date
Janus Henderson Group PLC3,458,8632026-03-31
Orbis Allan Gray Ltd2,472,4802026-03-31
Blackrock Inc.2,324,9292026-03-31
FMR, LLC2,160,9432026-03-31
Perceptive Advisors Llc2,035,9862026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACAD $29.21 +2.67% 8.94 $5.00B 0.00%
AKROAkero Therapeutics, Inc. $54.65 +0.00% -19.87 $4.50B 0.00%
CNTACentessa Pharmaceuticals plc $40.50 +0.00% -22.75 $6.27B 0.00%
CRNX $83.81 -0.09% -8.57 $8.87B 0.00%
IMVT $39.24 +1.91% -11.09 $8.06B 0.00%

About PRAX

PRAX is led by CEO Marcio Silva De'Souza, employs 168 people, headquartered in Boston, US, publicly traded since 2020.

PRAX stock trades at $303.02 with a market capitalization of $8.45B. The stock is valued at a price-to-earnings (P/E) ratio of -23.78, price-to-book of 7.72, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $37.19 and $366.52, and currently trades 17.3% below its 52-week high.

On profitability, PRAX generates a return on equity (ROE) of -34.51%, return on capital employed of -37.13%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides